Comparative effects of stretching respiratory accessory muscles and ribs mobilization to improve chest expansion in COPD patients.

Not Applicable

Conditions: Chest expansion in COPD.

Registration Number: IRCT20220514054851N1

Lead Sponsor: The university of faisalabad

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 50

Inclusion Criteria

Patients within age group of 30-55 years
Patients who are diagnosed with chronic obstructive pulmonary disease according to global initiative for chronic obstructive pulmonary disease
Patients with acute and moderate history of chronic obstructive pulmonary disease
Both males and females
Haemodynamically stable patients who will be willing participate in the study

Exclusion Criteria

Patients having lung carcinoma and acute inflammatory condition
Patients having cardiac or neuromuscular disease
Patients having recent surgery history and recent chest injury
Patients having severe or very severe history of chronic obstructive pulmonary disease
Corona virus disease of 2019 patients
Patients with broken ribs, bruised ribs, fractured ribs
Patients having Fibromyalgia
Patients with costochondritis
Patients having pleurisy

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chest expansion. Timepoint: Total 4 weeks of interventional period in which every week 3 sessions and assessment of chest expansion at baseline then after 2 weeks and again after 2 weeks. Method of measurement: Measuring tape.

Secondary Outcome Measures

Name	Time	Method
Vital capacity. Timepoint: Total 4 weeks of interventional period in which every week 3 sessions and assessment of chest expansion at baseline then after 2 weeks and again after 2 weeks. Method of measurement: Spirometry.;Dyspnea. Timepoint: Total 4 weeks of interventional period in which every week 3 sessions and assessment of chest expansion at baseline then after 2 weeks and again after 2 weeks. Method of measurement: Modified borg dyspnea scale.